Overview

Metformin Efficacy and Safety in Epileptic Patients

Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to Evaluating Metformin Efficacy and Safety when Co-administered with Antiepileptic Drugs in Patients with Seizures. The main question it aims to answer is: - Does metformin have beneficial effect on epileptic patients? - How metformin can affect epileptic patient's health? Participants will be divided into 2 groups (control group and treatment group) - Control group will receive standard treatment (levetiracetam). - Treatment group will receive standard treatment (levetiracetam) + metformin
Phase:
Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Levetiracetam
Metformin